Toggle light / dark theme

RNA technologies explained

The mRNA vaccine success story is one of the few positives to emerge from COVID-19. But these vaccines from Moderna and Pfizer/BioNTech are only the tip of the iceberg in the coming RNA medical technology revolution.

Australia, including our newly established UNSW RNA Institute, is well-placed to take a leading role in this revolution. With its eyes firmly set on making NSW a global force in the RNA industry, the NSW Government is backing a new RNA Bioscience Alliance between all the NSW Universities as well as funding a $15 million RNA production network between some of the state’s leading research organizations to bootstrap pre-clinical RNA research. UNSW’s RNA Institute is a key part of this drive, and with a $25 million investment brings together world-leading expertise to support the state and national agenda.

So beyond mRNA vaccines, what are these RNA therapeutics on the horizon? And what is the secret sauce that finally got mRNA vaccines to work after many years of trying? To understand this, let’s first tackle what RNA is and how it is used in medicine.

El Salvador Readies Bitcoin Rollout With 200 ATMs for Conversion

El Salvador began installing Bitcoin ATMs, allowing its citizens to convert the cryptocurrency into U.S. dollars and withdraw it in cash, as part of the government’s plan to make the token legal tender.

The government will install 200 of the teller machines to initially accompany its digital wallet called Chivo, a local slang term for ‘cool,’ President Nayib Bukele said on Twitter. Transactions will be commission free, he said, adding that there will also be 50 financial branches across the country for withdrawing or depositing money.

Hydrogen lobbyist quits, slams oil companies’ “false claims” about blue hydrogen

Jackson continues by saying that blue hydrogen is “at best an expensive distraction, and at worst a lock-in for continued fossil fuel use” which would derail goals that the country and the world have set for decarbonizing the economy. He takes particular issue with the fact that oil and gas companies have asked the UK government for decades of subsidies while also claiming that blue hydrogen will be inexpensive to produce. “If the false claims made by oil companies about the cost of blue hydrogen were true, their projects would make a profit by 2030,” he told The Guardian.


Recent studies have questioned blue hydrogen’s low-carbon bona fides.

The U.S. could be on the verge of a productivity boom, a game-changer for the economy

Economists have learned that new technological breakthroughs usually don’t cause a jump in productivity right away. The technology needs time to marinate so companies can test how best to deploy it in their industry. Brynjolfsson argues artificial intelligence and machine learning have now simmered long enough to make a dramatic difference. Others are not as convinced.


Rapid adoption of robots and artificial intelligence during the pandemic combined with a rebound in government investment is making some economists optimistic about a return of a 1990s economy with widespread benefits.

Electric cars and batteries: how will the world produce enough?

Battery-and carmakers are already spending billions of dollars on reducing the costs of manufacturing and recycling electric-vehicle (EV) batteries — spurred in part by government incentives and the expectation of forthcoming regulations. National research funders have also founded centres to study better ways to make and recycle batteries. Because it is still less expensive, in most instances, to mine metals than to recycle them, a key goal is to develop processes to recover valuable metals cheaply enough to compete with freshly mined ones. “The biggest talker is money,” says Jeffrey Spangenberger, a chemical engineer at Argonne National Laboratory in Lemont, Illinois, who manages a US federally funded lithium-ion battery-recycling initiative, called ReCell.


Reducing the use of scarce metals — and recycling them — will be key to the world’s transition to electric vehicles.

Bezos’s Blue Origin Challenges NASA Contract With Musk’s SpaceX

Jeff Bezos’s Blue Origin is challenging a U.S. government contract with Elon Musk’s SpaceX to develop technology to land people on the moon again.

In a complaint filed Friday in the Court of Federal Claims in Washington, Blue Origin said the National Aeronautics and Space Administration’s evaluation process was “unlawful and improper.” The complaint was filed under seal but tandem documents seeking a protective order gave an indication of its contents.

NASA selected SpaceX’s human lander bid on April 16 leading Blue Origin and a bidding partner, Dynetics Inc., to file protests with the Government Accountability Office less than two weeks later alleging that the award process was flawed. The GAO denied that protest on July 30 saying that NASA’s SpaceX selection had been made properly. Blue Origin, which has offered to contribute more than $2 billion of work on the project at no cost to the government, had vowed to continue pursuing the matter.

Facebook and Google are laying another giant undersea internet cable, this time stretching 7,500 miles between 6 Asian countries

Facebook and Google have both already laid thousands of miles of undersea internet cable together, and are in the process of laying thousands of miles more.

Google announced in June it would lay a cable linking the US East Coast to Argentina, and both companies announced in March they were funding two cables hooking up the US West Coast with Singapore and Indonesia.

Over the course of 2020 and early 2021, Google and Facebook both scrapped numerous projects linking the US with Hong Kong in response to political pressure with the US government, which cited security concerns.

Solar Orbiter Captures Venus’ Glare During Close Pass of Our Solar System’s Hottest Planet

On August 9 2021, ESA/ NASA

Established in 1,958 the National Aeronautics and Space Administration (NASA) is an independent agency of the United States Federal Government that succeeded the National Advisory Committee for Aeronautics (NACA). It is responsible for the civilian space program, as well as aeronautics and aerospace research. It’s vision is “To discover and expand knowledge for the benefit of humanity.”

Laser mining – the light at the end of the tunnel?

Laser mining would allow for a no explosive option and not need huge machines increasing output as well. Also lasers could make more precise cuts rather than blades which would never get dull.


The application of the “Graduated Optical Colimator” (GOC) for the mining industry consists of a one-kilowatt optical power fiber laser to selectively spall igneous geological formations containing narrow veins of precious metals.

Merger said the prototype addresses key issues like mining using less explosives, chemicals and waste.

“We’ve been working at this problem for five or six years now – and we’ve discovered that a lot of laboratory research has been done in the private sector and in the government sector,” Gary Mladjan, Merger Mines’ VP, engineering and technology told MINING.COM.

MSD Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19

U.S. government commits to purchase approximately 1.7 million courses of Molnupiravir upon issuance of Emergency Use Authorization or approval by the U.S. Food and Drug Administration.

KENILWORTH, N.J. 0 June 17 2021 /PRNewswire/ — Merck (NYSE: MRK), known as MSD outside the United States and Canada 0 today announced it has entered into a procurement agreement with the United States government for Molnupiravir (MK-4482). Molnupiravir is currently being evaluated in a Phase 3 clinical trial, the MOVe-OUT study, for the treatment of non-hospitalized patients with laboratory-confirmed COVID-19 and at least one risk factor associated with poor disease outcomes. MSD is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics.

“MSD is pleased to collaborate with the U.S. government on this new agreement that will provide Americans with COVID-19 access to molnupiravir – an investigational oral therapy being studied for outpatient use early in the course of disease – if it is authorized or approved,” said Rob Davis 0 president, MSD. “In addition to this agreement with the U.S. government, we are actively engaged in numerous efforts to make molnupiravir available globally to fulfill MSD’s commitment to widespread access.”